Heliospectra (Q1 Initial take): Top-line and Order Intake Beat - Redeye

Redeye provides its initial take on Heliospectra’s Q1 2026 results. The report is characterised by a solid beat on net sales and order intake, which both significantly exceeded our forecasts. However, this was contrasted by a gross margin that was much weaker than anticipated, leading to a bottom line (EBIT) that only aligned with expectations despite the higher revenue. The underlying commercial activity remains high with several large-scale projects in the pipeline.

Länk till analysen i sin helhet: https://www.redeye.se/research/1160384/heliospectra-q1-initial-take-top-line-and-order-intake-beat?utm_source=finwire&utm_medium=RSS